November 5, 2020 - a podcast by COVID19LST

In today's episode we discuss:

—Understanding the Pathology: Do childhood vaccines help protect against SARS-CoV-2? A team of Egyptian virologists inoculated mice with common childhood vaccines (BCG, Pneumococcal, Rotavirus, Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenzae, Meningococcal, Measles, Mumps, and Rubella) and found no evidence of cross-reacting antibodies against SARS-CoV-2 in serum up to seven weeks post-vaccination, suggesting that if childhood vaccines provide protection against SARS-CoV-2, it may not be antibody mediated.

—Transmission & Prevention: How often are discharged patients re-testing positive for SARS-CoV-2? A review of 62 studies evaluating recurrence of SARS-CoV-2 viral RNA in discharged COVID-19 patients found that the proportion of patients with re-positive RT-PCR ranged from 2.4% to 69.2% across studies, occurring from 1-38 days after discharge, which was attributed to false-negative tests prior to discharge, false positive tests following discharge, reinfection, reactivation, and intermittent viral shedding.

—Adjusting Practice During COVID-19: What treatment options should physicians consider for patients with psoriasis? Following a literature review, dermatologists from Tehran, Iran recommend not starting immunosuppressive drugs for psoriatic patients due to an increased risk of acquiring COVID-19 and instead encourage initiating and continuing low-risk immunomodulating drugs as a safer modality.

—R&D: Diagnosis & Treatments: Is there a correlation between vitamin D levels and COVID-19 severity? A retrospective study conducted by various medical institutions in Tehran, Iran investigated 73 subjects with confirmed COVID-19 and found mean serum vitamin D (25[OH]D) concentrations were significantly lower in the deceased compared to discharged patients, and higher 25(OH)D levels were associated with less extensive lung involvement, suggesting a potential correlation between vitamin D status and clinical course, extent of lung involvement, and patient outcome in COVID-19.

---

This episode is sponsored by
· Anchor: The easiest way to make a podcast. https://anchor.fm/app

Support this podcast: https://anchor.fm/covid19lst/support

Further episodes of The COVID-19 LST Report

Further podcasts by COVID19LST

Website of COVID19LST